Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
![Alex Azar](https://www.radiohc.cu/articles/3471-alex-azar-secretary.jpeg)
Artículos Relacionados
Comentarios
Deja un comentario
Todos los campos son requeridosMás Vistas
- Familias Indígenas del Oriente cubano en Festival internacional de Cine de Gibara
- Periodistas de Cuba relatan anécdotas con Fidel Castro
- Pinar del Río abraza al astro olímpico Mijaín López
- En los invencibles brazos de Mijaín, la bandera llega hoy a la Patria
- ONU por preservar comunidades indígenas en aislamiento voluntario